Health Care: Drugs

Raptor Pharmaceutical Corp (RPTP: NASDAQ)

$13 n/a | n/a%
09/02/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Aug 2012
Sales 69.50M 16.87M 0.00 0.00
Cost of Sales 6.75M 783.00K 0.00 0.00
Gross Operating Profit 62.74M 16.09M 0.00 0.00
Selling, General, and Administrative Expenses 56.65M 37.95M 8.97M 14.72M
Research & Development 43.48M 29.18M 8.96M 21.44M
Operating Income before D & A (EBITDA) -37.39M -51.04M -17.93M -36.17M
Depreciation & Amortization 2.66M 870.00K 91.00K 211.00K
Interest Income 76.00K 188.00K 160.00K 340.00K
Other Income - Net 1.46M -10.87M -1.44M -2.82M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -38.52M -62.58M -19.30M -38.85M
Interest Expense 13.97M 6.83M 83.00K 3.00K
Pre-Tax Income -52.49M -69.42M -19.38M -38.86M
Income Taxes 54.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -52.54M -69.42M -19.29M -38.64M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -52.54M -69.42M -19.29M -38.64M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -52.54M -69.42M -19.29M -38.64M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-52.54M -69.42M -19.29M -38.64M
Preferred Dividends
Net Income Available To Common -52.54M -69.42M -19.29M -38.64M
Basic EPS from Continuing Ops. -0.83 -1.20 -0.37 -0.80
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.83 -1.20 -0.37 -0.80
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.83 -1.20 -0.37 -0.80
Basic Normalized Net Income/Share -0.83 -1.20 -0.37 -0.80
EPS fr Continuing Ops. -0.83 -1.20 -0.37 -0.80
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.83 -1.20 -0.37 -0.80
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.83 -1.20 -0.37 -0.80
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.83 -1.20 -0.37 -0.80
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RPTP

Latest RPTP Headlines from TheStreet

More Financial News for RPTP

Press Releases for RPTP

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter